Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.
Sertoli MR, Santini G, Chisesi T, Congiu AM, Rubagotti A, Contu A, Salvagno L, Coser P, Porcellini A, Vespignani M, et al. Sertoli MR, et al. Among authors: coser p. J Clin Oncol. 1994 Jul;12(7):1366-74. doi: 10.1200/JCO.1994.12.7.1366. J Clin Oncol. 1994. PMID: 7517442 Clinical Trial.
VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group.
Santini G, Coser P, Congiu AM, Salvagno L, De Souza C, Sertoli MR, Olivieri A, Chisesi T, Rubagotti A, Truini M, Contu A, Porcellini A, Zambaldi G, Nati S, Marino G, Rizzoli V. Santini G, et al. Among authors: coser p. Haematologica. 2000 Feb;85(2):160-6. Haematologica. 2000. PMID: 10681723 Clinical Trial.
Cemp, a mitoxantrone containing combination, in the treatment of intermediate and high grade non-hodgkin's lymphoma: an effective and non toxic therapeutic alternative for adult and elderly patients.
Chisesi T, Polistena P, Contu A, Coser P, Indrizzi L, Leoni P, Majolino I, Porcellini A, Salvagno L, Zambaldi G, Rizzoli V, Congiu AM, Santini G; Non-Hodgkin's Lymphoma Co-operative Study Group (NHLCSG). Chisesi T, et al. Among authors: coser p. Leuk Lymphoma. 2001 Mar;41(1-2):125-36. doi: 10.3109/10428190109057961. Leuk Lymphoma. 2001. PMID: 11342364 Clinical Trial.
Mitoxantrone alone or in combination chemotherapy (VeMP) as second-line treatment in relapsed or refractory poor-prognosis non-Hodgkin's lymphoma. A report of the Non-Hodgkin's Lymphoma Co-operative Study Group (NHLCSG).
Santini G, Contu A, Porcellini A, Chisesi T, Coser P, Congiu AM, Morandi S, Manna A, Schintu GM, Quaini R, et al. Santini G, et al. Among authors: coser p. Haematologica. 1991 Nov-Dec;76(6):485-90. Haematologica. 1991. PMID: 1820985 Clinical Trial.
Autologous bone marrow transplantation for advanced stage adult lymphoblastic lymphoma in first complete remission. Report of the Non-Hodgkin's Lymphoma Cooperative Study Group (NHLCSG).
Santini G, Coser P, Chisesi T, Porcellini A, Sertoli R, Contu A, Vinante O, Congiu AM, Carella AM, D'Amico T, et al. Santini G, et al. Among authors: coser p. Ann Oncol. 1991 Feb;2 Suppl 2:181-5. doi: 10.1007/978-1-4899-7305-4_29. Ann Oncol. 1991. PMID: 2049316 Free article. Clinical Trial.
Randomized study of chlorambucil (CB) compared to interferon (alfa-2b) combined with CB in low-grade non-Hodgkin's lymphoma: an interim report of a randomized study. Non-Hodgkin's Lymphoma Cooperative Study Group.
Chisesi T, Congiu M, Contu A, Coser P, Moretti L, Porcellini A, Rancan L 6th, Salvagno L, Santini G, Vinante O. Chisesi T, et al. Among authors: coser p. Eur J Cancer. 1991;27 Suppl 4:S31-3. doi: 10.1016/0277-5379(91)90566-v. Eur J Cancer. 1991. PMID: 1799472 Clinical Trial.
80 results